In the US, employee-owned research agency Westat has appointed Mark Thompson as Vice President in its Clinical Research practice.

Westat offers research services to help clients improve outcomes in health, education, social policy and transportation. The firm's expertise includes data collection management, clinical trials, statistical research and survey methods, and evaluation.

Thompson (pictured) joins with more than 30 years' experience in clinical research and epidemiology, with specialisms in influenza and Covid-19 vaccines. During his career at the Centers for Disease Control and Prevention (CDC), he served as Principal Investigator on domestic and multi-country investigations of disease burden, immunogenicity, and vaccine effectiveness, including studies focused on pregnant women, infants, older adults and health care personnel. Earlier, he worked at Kaiser Permanente Northern California, where he led a clinical practice guidelines initiative.

In his new role, Thompson reports to Sunitha Mathew, Vice President and Practice Director, who comments: 'Mark brings a focus on applications of RWE and advanced analytics that will spark innovation and growth. Our team of clinical and epidemiological researchers, bioinformaticians, and data scientists is excited to work with him to address our federal and commercial clients' challenges'.

Web site: www.westat.com .

• Printer-friendly version of this article.
• Email this article to a friend.